UTA’s AbeXXa Biologics named one of 40 Best University Startups 2017 by NCET2

(University of Texas at Arlington) AbeXXa Biologics, a faculty startup at The University of Texas at Arlington, was named one of the 40 'Best University Startups 2017' by the National Council of Entrepreneurial Tech Transfer. AbeXXa is identifying a new series of biomarkers or targets for cancer from the many thousands of proteins found within a tumor cell, a new field of research that could potentially result in immunotherapies that prove effective for a broad range of patients.